Tvardi Therapeutics, Inc 10-K for FY2022
Tvardi Therapeutics, Inc. (TVRD)
10-K
2023-03-06
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 10-K
Tvardi Therapeutics, Inc filed this 10-K on March 6, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $41.87M
- up 81.8% from $23.03M a year earlier
- Net loss
- $85.47M
- compared with a net loss of $88.44M a year earlier
- Diluted EPS
- -$1.59
- compared with -$1.74 a year earlier